Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran

Seyed Moayed Alavian; Kamran B Lankarani; Seyed Hossein Aalaei-Andabili; Ali Pouryasin; Nasser Daryani; Mohsen Nasiritoosi; Reza Malekzadeh; Mohammad Reza Zali; Mino Mohraz

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue All Issues In Press Articles Accepted Manuscripts Search

Journal Information Boards and committees Indexing and Listing Sources Open Peer Review (OPR)Journal Metrics Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran

Author(s):

Seyed Moayed Alavian^1,*,

Kamran B Lankarani²,

Seyed Hossein Aalaei-Andabili¹,

Ali Pouryasin³,

Nasser Daryani⁴,

Mohsen Nasiritoosi⁴,

Reza Malekzadeh⁵,

Mohammad Reza Zali⁶,

Mino Mohraz⁷

1Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran

2Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran

3Islamic Azad University, Arsanjan Branch, Basic Science Faculty, Biology Department, Arsanjan, IR Iran

4Tehran University of Medical Sciences, Tehran, IR Iran

5Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran

6Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran,, IR Iran

7Iranian Research Center for HIV/AIDS (IRCHA), Tehran University of Medical Sciences, Tehran, IR Iran

Hepatitis Monthly:Vol. 11, issue 9; e93018

Published online:Sep 30, 2011

Article type:Review Article

Received:May 06, 2019

Accepted:Sep 30, 2011

How to Cite:Alavian S M, B Lankarani K, Aalaei-Andabili S H, Pouryasin A, Daryani N, et al. Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR Iran.Hepat Mon.2011;11(9):e93018.

Abstract

Complete name and affiliation of collaborators are listed at the end of this article as an Appendix ( page: 711 ).

Hepatitis C remains as an important health problem worldwide. Hepatitis C treatment, especially among patients infected with HCV genotype 1 who are considered difficult to treat, is a high priority for health policy-makers. PegInterferon alfa instead of Interferon and ribavirin combination therapy has been accepted as the standard treatment regimen for hepatitis C patients; however, only 50% of patients infected with HCV genotype 1 achieve a sustained virological response. Published data from various clinical trials of protease inhibitors suggest that new therapeutic regimens may increase the chances of a successful response in patients infected with HCV genotype 1. Triple therapy that includes boceprevir has been shown to result in high rates of sustained virological response in both naive and experienced patients with HCV genotype 1 infection. In this review, we have summarized the results obtained with this new regimen and have attempted to provide a guideline for the treatment of patients in Iran, with emphasis on cost and the occurrence of adverse events.

Implication for health policy/practice/research/medical education:
Proper treatment of hepatitis C to control the burden of disease is essential in the society. Nowadays with the new methods of therapy the hope of eradication is more than before. This study is recommended to internal medicine and infectious disease specialists, gastroenterologists, general practitioners, virologists and health policy makers.

Please cite this paper as:
Alavian SM, Lankarani KB, Aalaei-Andabili SH, Pouryasin A, Ebrahimi Daryani N, Nassiri Toosi M, et al. Treatment of Chronic Hepatitis C Infection: Updated of the Recommendations from Scientific Leaders' Meeting-28th July 2011-Tehran, IR Iran. Hepat Mon. 2011; 11(9):703-13. DOI: 10.5812/kowsar.1735143X.769

Keywords

References

1.
The references are available in the PDF file.

comments